Sustained MRD Negativity for Three Years Can Guide Discontinuation of Lenalidomide Maintenance after ASCT in Multiple Myeloma: Results from a Prospective Cohort Study
Authors
Panagiotis Malandrakis,
Ioannis Ntanasis-StathopoulosIoannis Kostopoulos,
Vasiliki Spiliopoulou,
Despina Fotiou,
Foteini Theodorakakou,
Magdalini Migkou,
Nikolaos Kanellias,
Evangelos Eleutherakis‐Papaiakovou,
Efstathios Kastritis,
Maria Gavriatopoulou,
Ourania Tsitsilonis,
Meletios Dimopoulos +11 authors
,
Evangelos Terpos
Tip
Tip